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ABSTRACT
Serotonin and a1 adrenergic receptor antagonism may contribute to atypical
antipsychotic drug effects. Clozapine (2.5 mglkg) drug discrimination in C57BL16 mice
may selectively screen atypical antipsychotic drugs. Previous data show that the atypical
antipsychotics olanzapine, risperidone, ziprasidone but not the typical antipsychotic
haloperidol fully substitutes for clozapine. The present study demonstrated that the
atypical antipsychotics quetiapine, sertindole, zotepine, iloperidone, melperone fully
substituted for clozapine but aripiprazole did not. The typical antipsychotics fluphenazine
and perphenazine failed to fully substitute for clozapine but chlorpromazine and
thioridazine fully substituted for clozapine. This model does not differentiate between
atypical and typical antipsychotic drugs but it may be useful in the detection of
antipsychotics with potent serotonin and a1 adrenergic receptor antagonist actions.

